Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ferroportin disease due to the A77D mutation in Australia.

Literature DB >> 15951560

Ferroportin disease due to the A77D mutation in Australia.

V N Subramaniam, D F Wallace, J L Dixon, L M Fletcher, D H Crawford.

Abstract

Entities: Mutation

Mesh：

Substances：

Year: 2005 PMID： 15951560 PMCID： PMC1774624 DOI： 10.1136/gut.2005.069021

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

8 in total

1. A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.

Authors: Antonella Roetto; Alison T Merryweather-Clarke; Filomena Daraio; Karen Livesey; Jennifer J Pointon; Giuliana Barbabietola; Antonio Piga; Peter H Mackie; Kathryn J H Robson; Clara Camaschella
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

2. Identification of ferroportin disease in the Indian subcontinent.

Authors: D F Wallace; P Browett; P Wong; H Kua; R Ameratunga; V N Subramaniam
Journal: Gut Date: 2005-04 Impact factor: 23.059

3. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.

Authors: O T Njajou; N Vaessen; M Joosse; B Berghuis; J W van Dongen; M H Breuning; P J Snijders; W P Rutten; L A Sandkuijl; B A Oostra; C M van Duijn; P Heutink
Journal: Nat Genet Date: 2001-07 Impact factor: 38.330

4. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).

Authors: Mario Cazzola; Laura Cremonesi; Maria Papaioannou; Nadia Soriani; Anna Kioumi; Anastasia Charalambidou; Rita Paroni; Katerina Romtsou; Sonia Levi; Maurizio Ferrari; Paolo Arosio; John Christakis
Journal: Br J Haematol Date: 2002-11 Impact factor: 6.998

5. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

Authors: Vinod Devalia; Kymberley Carter; Ann P Walker; Stephen J Perkins; Mark Worwood; Alison May; James S Dooley
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

6. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.

Authors: Daniel F Wallace; Palle Pedersen; Jeannette L Dixon; Peter Stephenson; Jeffrey W Searle; Lawrie W Powell; V Nathan Subramaniam
Journal: Blood Date: 2002-07-15 Impact factor: 22.113

Review 7. The ferroportin disease.

Authors: Antonello Pietrangelo
Journal: Blood Cells Mol Dis Date: 2004 Jan-Feb Impact factor: 3.039

8. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.

Authors: G Montosi; A Donovan; A Totaro; C Garuti; E Pignatti; S Cassanelli; C C Trenor; P Gasparini; N C Andrews; A Pietrangelo
Journal: J Clin Invest Date: 2001-08 Impact factor: 14.808

8 in total

1. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.

Authors: Zhiyong Deng; David H Manz; Suzy V Torti; Frank M Torti
Journal: Antioxid Redox Signal Date: 2017-12-11 Impact factor: 8.401

Review 2. Non-HFE haemochromatosis.

Authors: Daniel-F Wallace; V-Nathan Subramaniam
Journal: World J Gastroenterol Date: 2007-09-21 Impact factor: 5.742

Review 8. Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors: L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal: Pharmaceuticals (Basel) Date: 2019-09-09

8 in total

Ferroportin disease due to the A77D mutation in Australia.

1. A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.

2. Identification of ferroportin disease in the Indian subcontinent.

3. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.

4. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).

5. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

6. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.

Review 7. The ferroportin disease.

8. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.

1. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.

Review 2. Non-HFE haemochromatosis.

3. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

4. Human macrophage ferroportin biology and the basis for the ferroportin disease.

5. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.

Review 6. Clinical and Molecular Aspects of Iron Metabolism in Failing Myocytes.

Review 7. Ferroportin disease: pathogenesis, diagnosis and treatment.

Review 8. Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.